These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28091641)

  • 1. Effects of pomegranate extract in supplementing gonadotropin-releasing hormone therapy on idiopathic central precocious puberty in Chinese girls: a randomized, placebo-controlled, double-blind clinical trial.
    Liu J; Tang J
    Food Funct; 2017 Feb; 8(2):695-700. PubMed ID: 28091641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of domestic leuprorelin in girls with idiopathic central precocious puberty: a multicenter, randomized, parallel, controlled trial.
    Li WJ; Gong CX; Guo MJ; Xing J; Li T; Song WH; Luo XP; Wu D; Liang JP; Cao BY; Gu Y; Su C; Liang XJ; Liu M; Wang R; Li FT
    Chin Med J (Engl); 2015 May; 128(10):1314-20. PubMed ID: 25963350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
    Pasquino AM; Pucarelli I; Accardo F; Demiraj V; Segni M; Di Nardo R
    J Clin Endocrinol Metab; 2008 Jan; 93(1):190-5. PubMed ID: 17940112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 levels in children with precocious puberty treated with gonadotropin-releasing hormone analog without or in combination with cyproterone acetate.
    Verrotti A; Ferrari M; Sabatino G; Morgese G; Chiarelli F
    Gynecol Endocrinol; 1997 Aug; 11(4):243-50. PubMed ID: 9272420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of gonadotropin releasing hormone analog and growth hormone on height in girls with idiopathic central precocious puberty].
    Wang CL; Liang L; Liu PN; Jin XJ; Chen LQ; Yang F; Lian Q; Chen RM
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jan; 16(1):25-30. PubMed ID: 24461173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating ghrelin levels in girls with central precocious puberty are reduced during treatment with LHRH analog.
    Maffeis C; Franceschi R; Moghetti P; Camilot M; Lauriola S; Tatò L
    Eur J Endocrinol; 2007 Jan; 156(1):99-103. PubMed ID: 17218731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
    Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of gonadotropin-releasing hormone analog combined with stanazolol on final height in girls with idiopathic central precocious puberty and apparent decrease of linear growth].
    Li YH; Zhu SY; Ma HM; Su Z; Chen HS; Chen QL; Gu YF; Du ML
    Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):807-12. PubMed ID: 24484553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth, growth hormone and sex steroid secretion in girls with central precocious puberty treated with a gonadotrophin releasing hormone (GnRH) analogue.
    Stanhope R; Pringle PJ; Brook CG
    Acta Paediatr Scand; 1988 Jul; 77(4):525-30. PubMed ID: 3293348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent relationship between body mass index and LH peak value of GnRH stimulation test in ICPP girls: A cross-sectional study.
    Zhao Y; Hou L; Gao HJ; Zhan D; Zhang C; Luo XP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):556-562. PubMed ID: 28786058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of leuprolide therapy in children with central precocious puberty.
    Kappy MS; Stuart T; Perelman A
    Am J Dis Child; 1988 Oct; 142(10):1061-4. PubMed ID: 3140654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Anti-Müllerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment.
    Nam HK; Kim HR; Rhie YJ; Lee KH
    J Korean Med Sci; 2017 Mar; 32(3):475-479. PubMed ID: 28145651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.
    Sklar CA; Rothenberg S; Blumberg D; Oberfield SE; Levine LS; David R
    J Clin Endocrinol Metab; 1991 Oct; 73(4):734-8. PubMed ID: 1909701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral content in girls with precocious puberty treated with gonadotropin-releasing hormone analog.
    Verrotti A; Chiarelli F; Montanaro AF; Morgese G
    Gynecol Endocrinol; 1995 Dec; 9(4):277-81. PubMed ID: 8629454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].
    Liang Y; Wei H; Zhang JL; Hou L; Luo XP
    Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):845-9. PubMed ID: 15631714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteinizing Hormone Secretion during Gonadotropin-Releasing Hormone Stimulation Tests in Obese Girls with Central Precocious Puberty.
    Lee HS; Yoon JS; Hwang JS
    J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):392-398. PubMed ID: 27215137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.